Regulation of the ABCG5 ABCG8 Sterol Transporter

ABCG5 ABCG8 甾醇转运蛋白的调节

基本信息

  • 批准号:
    8274829
  • 负责人:
  • 金额:
    $ 31.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

6. Project Summary The purpose of this project is to determine the mechanisms by which leptin regulates the ABCG5 ABCG8 (G5G8) sterol transporter and influences cholesterol metabolism in obesity. Obesity and diabetes (diabesity) are associated with increased risk of cardiovascular and gallbladder disease, elevated plasma cholesterol levels, and a predilection for cholesterol synthesis rather than absorption. High-fat diets induce a virtually identical phenotype in mice. In contrast, mice that lack leptin (ob/ob) or its receptor (db/db) are hyperphagic, obese and diabetic, yet exhibit increased cholesterol absorption, reduced cholesterol synthesis, decreased biliary cholesterol, and resistance to cholethiasis. These observations suggest that in obesity the presence or absence of a functional leptin axis profoundly impacts cholesterol metabolism with respect to absorption, synthesis and hepatobiliary transport. The central hypothesis of this proposal is that hepatic leptin signaling maintains G5G8 and prevents reductions in hepatobiliary cholesterol transport by ER stress in diabesity. The Aims are to 1) determine the role of hepatic leptin receptors on G5G8 abundance, activity and cholesterol metabolism in vivo, 2) determine the role of ER stress on G5G8 abundance in vivo and 3) determine the molecular mechanisms for regulation of G5G8 abundance by leptin, ER stress and the ISR. Leptin receptors will be selectively deleted from liver and brain to assess the role of this signaling pathway on G5G8 and cholesterol metabolism in obesity. The effects of leptin, ER stress and their interaction on G5G8 abundance will be determined in vivo and in vitro. The completion of these Aims will test our central hypothesis and elucidate the mechanisms by which the leptin axis modulates G5G8 abundance, hepatobiliary lipid transport and cholesterol metabolism in diabesity. Understanding the impact of this novel pathway on cholesterol metabolism will add insight to the effects of obesity on risk factors for cardiovascular disease.
6.项目摘要 该项目的目的是确定瘦素调节ABCG 5 ABCG 8的机制 (G5 G8)固醇转运蛋白,并影响肥胖症的胆固醇代谢。 肥胖和糖尿病(糖尿病)与心血管和胆囊疾病的风险增加有关, 升高的血浆胆固醇水平,以及胆固醇合成而不是吸收的偏好。高脂肪 饮食在小鼠中诱导几乎相同的表型。相反,缺乏瘦素(ob/ob)或其受体的小鼠, (db/db)是贪食的、肥胖的和糖尿病的,但表现出增加的胆固醇吸收,降低的胆固醇 胆固醇合成、降低胆固醇和抗胆固醇。这些观察表明,在 肥胖功能性瘦素轴的存在或缺乏深刻地影响胆固醇代谢, 在吸收、合成和肝胆转运方面。 该提议的中心假设是肝脏瘦素信号传导维持G5 G8并防止减少 在糖尿病患者ER应激肝胆胆固醇转运中作用。目标是:1)确定 肝脏瘦素受体对G5 G8丰度、活性和体内胆固醇代谢的影响; 2)确定作用 ER应激对体内G5 G8丰度的影响; 3)确定G5 G8调控的分子机制 通过瘦素、ER应激和ISR的丰度。瘦素受体将被选择性地从肝脏和大脑中删除, 评估该信号通路在肥胖症中对G5 G8和胆固醇代谢的作用。瘦素的作用, 将在体内和体外确定ER应激及其对G5 G8丰度的相互作用。 这些目标的完成将检验我们的中心假设,并阐明瘦素的作用机制。 轴调节G5 G8丰度,肝胆脂质转运和胆固醇代谢的糖尿病。 了解这种新途径对胆固醇代谢的影响将有助于了解 肥胖对心血管疾病危险因素的影响。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory A Graf其他文献

Gregory A Graf的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory A Graf', 18)}}的其他基金

Don S. Fredrickson Lipid Research Conference
唐·S·弗雷德里克森脂质研究会议
  • 批准号:
    10752509
  • 财政年份:
    2023
  • 资助金额:
    $ 31.12万
  • 项目类别:
The Don S. Fredrickson Lipid Research Conference
唐·弗雷德里克森脂质研究会议
  • 批准号:
    10539150
  • 财政年份:
    2022
  • 资助金额:
    $ 31.12万
  • 项目类别:
Contributions of hepatic and intestinal pathways to cholesterol excretion
肝脏和肠道途径对胆固醇排泄的贡献
  • 批准号:
    9447975
  • 财政年份:
    2017
  • 资助金额:
    $ 31.12万
  • 项目类别:
Contributions of hepatic and intestinal pathways to cholesterol excretion
肝脏和肠道途径对胆固醇排泄的贡献
  • 批准号:
    9750695
  • 财政年份:
    2017
  • 资助金额:
    $ 31.12万
  • 项目类别:
Contributions of hepatic and intestinal pathways to cholesterol excretion
肝脏和肠道途径对胆固醇排泄的贡献
  • 批准号:
    10222657
  • 财政年份:
    2017
  • 资助金额:
    $ 31.12万
  • 项目类别:
Contributions of Hepatic and Intestinal Pathways to Cholesterol Excretion
肝脏和肠道途径对胆固醇排泄的贡献
  • 批准号:
    10656625
  • 财政年份:
    2017
  • 资助金额:
    $ 31.12万
  • 项目类别:
The role of hepatic insulin resistance on SR-BI dependant HDL cholesterol uptake
肝脏胰岛素抵抗对 SR-BI 依赖性 HDL 胆固醇摄取的作用
  • 批准号:
    9235659
  • 财政年份:
    2013
  • 资助金额:
    $ 31.12万
  • 项目类别:
The role of hepatic insulin resistance on SR-BI dependant HDL cholesterol uptake
肝脏胰岛素抵抗对 SR-BI 依赖性 HDL 胆固醇摄取的作用
  • 批准号:
    8613990
  • 财政年份:
    2013
  • 资助金额:
    $ 31.12万
  • 项目类别:
The role of hepatic insulin resistance on SR-BI dependant HDL cholesterol uptake
肝脏胰岛素抵抗对 SR-BI 依赖性 HDL 胆固醇摄取的作用
  • 批准号:
    8737894
  • 财政年份:
    2013
  • 资助金额:
    $ 31.12万
  • 项目类别:
Regulation of the ABCG5 ABCG8 Sterol Transporter
ABCG5 ABCG8 甾醇转运蛋白的调节
  • 批准号:
    7881405
  • 财政年份:
    2009
  • 资助金额:
    $ 31.12万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.12万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了